Lexaria Bioscience Corp. LEXX
NASDAQ · United States · Health Technology
$3.090.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 2026-07-13 | -1.20 | -0.90 | -33.3% | $0 | — | -9.3%$9.70→$8.81 |
| Q2 2026 | 2026-04-13 | -0.90 | -1.05 | +14.3% | — | — | +12.1%$13.65→$15.30 |
| Q1 2026 | 2026-01-13 | -1.05 | -1.95 | +46.2% | — | — | +1.6%$11.55→$11.73 |
| Q4 2025 | 2025-11-26 | -1.95 | -2.35 | +17.0% | — | — | +0.9%$16.20→$16.35 |
| Q3 2025 | 2025-07-14 | -3.15 | -2.17 | -45.2% | — | — | — |
| Q2 2025 | 2025-04-14 | -2.25 | -2.45 | +8.2% | — | — | — |
| Q1 2025 | 2025-01-10 | -2.40 | -1.80 | -33.3% | — | — | — |
| Q4 2024 | 2024-11-26 | -2.25 | -1.70 | -32.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.